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Abstract 
Recent studies demonstrated endogenous expression level of Sox2, Oct-4 and 
c-Myc is correlated with the pluripotency and successful induction of induced 
pluripotent stem cells (iPSCs). Periodontal ligament cells (PDLCs) have multi-lineage 
differentiation capability and ability to maintain undifferentiated stage, which makes 
PDLCs a suitable cell source for tissue repair and regeneration. To elucidate the effect 
of in vitro culture condition on the stemness potential of PDLCs, we explored the cell 
growth, proliferation, cell cycle, and the expression of Sox2, Oct-4 and c-Myc in 
PDLCs from passage 1 to 7 with or without the addition of recombinant human BMP4 
(rhBMP4). Our results revealed that BMP-4 promoted cell growth and proliferation, 
arrested PDLCs in S phase of cell cycle and upregulated PI value. It was revealed that 
without the addition of rhBMP4, the expression of Sox2, Oct-4 and c-Myc in PDLCs 
only maintained nucleus location until passage 3, then lost nucleus location 
subsequently. The mRNA expression in PDLCs further confirmed that the level of 
Sox2 and Oct-4 peaked at passage 3, then decreased afterwards, whereas c-Myc 
maintained consistently upregulation along passages. After the treatment with 
rhBMP4, the expression of Sox2, Oct-4 and c-Myc in PDLCs maintained nucleus 
location even at passage 7 and the mRNA expression of Sox2 and Oct-4 significantly 
upregulated at passage 5 and 7. These results demonstrated that addition of rhBMP-4 
in the culture media could improve the current culture condition for PDLCs to 
maintain in an undifferentiated stage. 
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Introduction 
Periodontal ligament cells (PDLCs), which contains progenitor cells at various stages 
of differentiation, are promising cell source for dental regeneration since they are easy 
accessible resource [1,2]. PDLCs possess mesenchymal stem cell (MSC) 
characteristics including self-renewal, multi-lineage differentiation capabilities and 
colony-forming efficiency [1,2]. However, the current cell culture methods always 
lead to the loss of stem cell characteristics in PDLCs. Recently, there has been a 
growing interest in the expression of Oct-4, Sox2, c-Myc and Klf4 in MSC cultures 
due to their correlation with the reprogramming of fibroblast cells to induced 
pluripotent stem cells (iPSCs). iPSCs show similar phenotype of embryonic stem cells 
(ESCs) with self-renewal, multi-lineage differentiation and colony-forming efficiency 
[4].  
 
The endogenous expression level of Sox2, Oct-4 and c-Myc has been shown to be 
correlated with the successful induction of iPSCs and the pluripotency [7]. MSCs 
from dental tissues have shown potential to be reprogrammed by introducing 
Oct-4/Sox2/Klf4/c-Myc or Oct-4/Sox2/Nanog/Lin28 [5,6]. It is also known that 
cellular stresses (including heat shock, oxidative stress and hypoxia) are able to 
activate signal which leads somatic cells to reprogramming and regeneration [9]. In 
our previous study, it has been demonstrated that ischemic culture stimulated the 
expression of Oct-4 and ABCG2 in human dental pulp cells [10]. Therefore, it is 
possible that the pluripotency network can be re-established or activated in somatic 
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 4 
cells [11].  
Bone morphogenetic protein-4 (BMP-4), a member of the transforming growth factor 
beta (TGFβ ) superfamily, can control vasculogenesis, induce embryonic and 
extraembryonic mesoderm formation in embryo [12]. BMP-4 stimulates the formation 
and outgrowth of pericytes in blood vessel formation and maintenance, which may be 
the origin of stem cell niche [13]. Furthermore, BMP-4 increases the proportion of 
Oct-4 positive cells in parthenogenic embryos during maturation, indicating BMP-4 
may provide a suitable microenvironment to maintain cells in an undifferentiated 
stage [14]. However, to date, the specific role of BMP-4 in maintaining stemness of 
PDLCs has not been elucidated yet. In the present study, we investigated cell growth, 
proliferation, cell cycle and altered expression of reprogramming markers (Sox2, 
Oct-4, c-Myc) in PDLCs at various passages with or without the addition of 
recombinant human BMP4 (rhBMP4) in the culture media. 
 
Materials and Methods 
Isolation and expansion of human PDLCs 
The protocols used (EC00171) were approved by Human Ethics Committee from 
Queensland University of Technology (QUT). Normal human premolars were 
extracted from healthy young adults (12-30 years) undergoing orthodontic treatment, 
after obtaining informed consent from each patient. PDLCs from three individual 
patients were used in each experiment and each experiment was repeated three times. 
The PDLCs from each patient were not pooled; instead, they were cultured and 
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 5 
studied separately according to the previous publications [15]. No significant 
variation was found among various patients. PDLCs were obtained from periodontal 
ligament tissues by explant culture as previously described [15]. PDLCs were cultured 
in Dulbecco’s modified Eagle medium with low glucose (DMEM-LG, Invitrogen, 
VIC, Australia) supplemented with 10% fetal bovine serum (FBS, HyClone, UT, US), 
10U/ml penicillin G, and 10mg/ml streptomycin (Invitrogen, VIC,  Australia). 
PDLCs were incubated at 37°C in 5%CO2 and characterized to the multi-lineage 
differentiation capability, the expression of cell surface markers STRO-1, CD146, 
CD44 etc, and the differentially expressed proteins and genes according to our 
previous studies [2,3]. rhBMP4 (R&D system, CA, USA) at the optimum 
concentration of 10ng/ml indicated by previous studies was added to culture medium 
throughout the suspension period [16]. Cells cultured in normal medium served as 
controls. The medium was changed every 3 days. The images of cells morphology 
were captured under an inverted light microscope. 
 
Beta-galactosidase staining for cell senescence 
Cytochemical staining for senescence-associated beta (β)-galactosidase assay was 
performed by seeding PDLCs from passage 1, 3, 5 and 7 at the cell density of 1×103 
cells/well in a 24-well plate. The cells were allowed to attach overnight and then were 
washed with PBS, fixed and incubated overnight at 37°C with X-gal chromogenic 
substrate at pH 6.0 according to the protocol provided by the β-galactosidase 
staining kit (Cell Signaling Technology, Beverly, MA). The images of cells 
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 6 
morphology were captured under an inverted light microscope. 
 
Cell counting kit 8 (CCK8) assay for cell proliferation 
The cell growth was measured by means of cell counting. Cell proliferation was 
investigated by cell counting kit 8 (CCK8) assay. The culture of PDLCs were serum 
deprived for 24h prior to the induction. A total of 10
4
 cells per well were plated in 
96-well plates and cultured for 24h in normal conditions with/without rhBMP4 
induction. Cell proliferation of PDLCs from passage 1 to 7 was evaluated using the 
CCK8 (Dojindo, Tokyo, Japan) according to manufacturer’s instructions. Briefly, 10μl 
of CCK8 solution was added to the culture medium, and incubated for additional 3h. 
The absorbance was determined at 450 nm wavelength. 
 
Flow cytometry for cell cycle analysis 
The culture of PDLCs were serum deprived for 24h prior to the induction. 1×105 
PDLCs from passage 1 to 8 with/without rhBMP4 treatment were harvested by 
trypsinization, washed twice in cold PBS, and fixed in 70% alcohol for 30 min on ice. 
After washing in cold PBS three times, cells were incubated with 0.5% propidium 
iodinate (PI) for 30 minutes at 4°C. Cells were analyzed using a FACSCalibur flow 
cytometer (BD Biosciences, San Jose, CA, U.S.). Each condition was repeated in 
triplicate. Data was analyzed using FCSExpress software.  
 
Immunofluorescent staining and nucleus expression ratio of reprogramming 
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markers in PDLCs at various passages 
PDLCs from passage 1 to 7 were cultured in chamber slides (Nunc, NY, US) until 
80% confluence, fixed with 3% paraformalehyde for 15min. The slides were rinsed in 
PBS three times for 5min respectively, then permeabilized with 0.1% Triton for 20min, 
and incubated with 10% swine serum for 1h at RT. Slides were transferred to a 
humidified chamber and stained with Sox2 (1:50, R&D system, MN, USA), Oct-4 
(1:100, Chemicon, CA, USA) and c-Myc (1:50, Santa Cruz, CA, USA) antibodies 
overnight at 4ºC. Samples were washed three times in PBS and incubated with a 
fluorochrome labeled secondary antibody (1:150, invitrogen, VIC, Australia) for 3h, 
then mounted for analysis. The images were captured under a Zeiss fluorescent 
microscope. The number of positive cells expressing Sox2, Oct-4 and c-Myc were 
measured in three randomly chosen areas from three different patients. The expression 
ratios of reprogramming markers in nucleus were determined by the positive cells 
numbers dividing with the total cell numbers. 
 
Quantitative Real-time reverse-transcription polymerase chain reaction 
Total RNA was isolated from PDLCs at passage 1 to 7 using Trizol reagent 
(Invitrogen, VIC, Australia) following the manufacturer’s protocol. The concentration 
and quality of RNA samples were measured with spectrophotometers and gel 
electrophoresis. First strand cDNA was synthesized from 1µg of total RNA using 
SuperScript III (Invitrogen, VIC, Australia) in a total volume of 20μL. 2.5 μL of the 
reaction mixture was incubated with 2×SYBR Green I Master Mix (Applied 
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 8 
Biosystems, VIC, Australia) in a total volume of 25μL. Primers used for detection 
were listed in Table 1. The conditions for PCR were as follows: 95
o
C for 10min for 
activation, followed by 40 cycles of denaturation at 95
o
C for 15s each, and finally, 
primer extension at 60
o
C for 1min. Quantifications of Sox2, Oct-4, c-Myc, BMP-4  
and 18s mRNA were performed using an ABI Prism 7000 sequence detection system 
(Applied Biosystems). Each plate contained 18s as housekeeping gene to normalize 
the PCR data. All experiments were repeated three times from three separate samples. 
Raw data were acquired and processed to calculate the threshold cycle (Ct) value and 
relative gene expression values. Delta delta Ct method was performed to analyze the 
result. 
 
Statistical analysis 
All experiments were repeated at least three times. The SPSS16.0 software package 
(SPSS Inc, Chicago, IL) was used for the statistical tests. One-way analysis of 
variance (ANOVA) was applied to compare the differences among passages. If 
equality of variances could be assumed, which was also concluded by a hypothesis 
test, Bonferroni test was performed. The difference was considered as being of 
statistical significance at p<0.05. Comparisons between rhBMP4 treated cells and the 
control cells at each passages were determined using the Student’s t-test. *P <0.05 
was considered to be significant. 
 
Results 
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Morphological alternations and cell senescence of PDLCs at various passages 
PDLCs at passage 1 displayed well-spread attachment to the flask, showed 
fibroblast-like morphology and single monolayer growing pattern (Fig 1A). PDLCs at 
passage 3 (Fig 1B), passage 5 (Fig 1C) and passage 7 (Fig 1D) showed signs of cell 
senescence, including alternations in cell morphology with enlarged size, increased 
nuclear/cytoplasm ratio. No difference in the morphology was observed using 
microscopic observation between normal and rhBMP4 treated groups at early 
passages (passage 1 to 3, data not shown). However, PDLCs with rhBMP4 treatment 
at passage 7 (Fig 1E) showed smaller cell size, decreased nuclear/cytoplasm ratio and 
cell secretion compared with the untreated groups (Fig 1D).  
 
To further authenticate the replicative senescence state of PDLCs at various passages, 
their senescence-associated β-galactosidase activity (SA-β-gal) was assessed. The 
β-galactosidase is an enzyme expressed by senescent cells. This assay revealed that 
PDLCs at passage 7 were strongly positive for SA-β-gal activity, which stained an 
intense blue color (Fig. 1I), PDLCs from passage 5 (Fig. 1H) showed blue staining 
but not as intense as the cells from passage 7. However, PDLCs from passage 1 (Fig. 
1F), passage 3 (Fig. 1G) and rhBMP4 treated group (passage 7, Fig. 1J) did not show 
any obvious blue staining, indicating PDLCs from early passage were pre-senescent, 
and BMP-4 may maintain PDLCs at an pre-senescent state. 
 
Cell growth, proliferation and cell cycle of PDLCs at various passages 
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To investigate the biological effect of rhBMP, cell number, proliferation and cell cycle 
of PDLCs at various passages were investigated after treatment. The cell number of 
PDLCs with rhBMP4 treatment was significantly increased at various passage 
compared with the control groups (Fig 2I, *p<0.05). As shown in Figure 2J, treatment 
with rhBMP significantly stimulated the cell proliferation of PDLCs at passage 5 and 
7 (Fig 2J, *p<0.05), albeit no significant difference at passage 1 and 3 (Fig 2J, 
p>0.05). These data indicate that cell growth and proliferation can be significantly 
stimulated by BMP-4. 
 
Since the effect of BMP-4 on the stimulation of cell growth and proliferation may 
result from cell cycle effects, thus the cell cycle distribution of rhBMP4 treated and 
control group PDLCs at various passages was investigated by Flow cytometry. As 
shown in Figure 2 A-H, 2K and Table 2, rhBMP4 arrested PDLCs from various 
passages in the S phase of the cell cycle, as demonstrated by an significant increase in 
the percentage of cells in S phase (passage 1 to 8, Fig2 A-H, 2K & Table 2, *P < 0.05, 
** P < 0.001) and G2/M (passage 1, 2 and 6, Fig 2 A-H, 2K & Table 2, *P < 0.05) 
with a corresponding decline in G0/G1 phase (passage 1 to 8, Fig 2 A-H, 2K & Table 
2, *P < 0.05). Notably, the percentage of PI=(S+G2/M)% in rhBMP4 treated PDLCs 
from passage 1 to 8 were significantly higher than the control group (Fig2A-H, 3C & 
Table 2, *P < 0.05, ** P < 0.001). These results imply that BMP-4 may promote cell 
growth and proliferation of PDLCs, especially from late passages, through arresting 
cells in S and G2/M phase of cell cycle and enhancing PI value.  
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Subcellular localization and nucleus expression ratio of Sox2, Oct-4 and c-Myc in 
PDLCs at various passages 
Immunofluorescent staining of Sox2, Oct-4 and c-Myc was investigated in PDLCs 
from passage 1 to 7, representative figures at passage 1, 3, 5 and 7 were provided (Fig 
3). The expression of Sox2 (Fig 3A-D), Oct-4 (Fig 3F-I) and c-Myc (Fig 3K-N) was 
obviously detected in the nucleus and slightly expressed in the cytoplasm of PDLCs at 
passage 1 and 3. Along with passages, Sox2, Oct-4 and c-Myc all lost nucleus 
location and maintained weak cytoplasm staining at passage 5 and 7. The nucleus 
expression ratio of Sox2 (Fig 4A), Oct-4 (Fig 4B) and c-Myc (Fig 4D) showed a 
similar expression pattern and altered in a passage-dependent manner, displayed no 
significant difference between passage 1 and 3 (p>0.05), but significantly decreased 
at passage 5 and 7 (*p<0.05).  
 
After treated with rhBMP4, Sox2 (Fig 3E), Oct-4 (Fig 3J) and c-Myc (Fig 3O) 
maintained nucleus location even at passage 7, whereas the control groups at passage 
7 (Fig 3D, I and N) all lost nucleus location without rhBMP4 induction. The nucleus 
expression ratio showed there was no significant difference between the rhBMP4 
induced and control group at passage 1 and 3 (Fig 4A, B and C, p>0.05), albeit 
significantly higher expression ratio of all three markers at passage 5 and 7 compared 
with the control groups (*p<0.05). 
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mRNA expression of Sox2, Oct-4, c-Myc and BMP-4 in PDLCs at various 
passages 
PDLCs from passage 1 to 7 were examined for Sox2, Oct-4 and c-Myc mRNA 
expression by real-time PCR, the results of typical passages which showed the trend 
were presented (Fig 4D, E and F). mRNA expression of Sox2 (Fig 4D) and Oct-4 (Fig 
4E) increased and peaked at passage 3, then decreased afterwards. mRNA expression 
of c-Myc (Fig 4F), however, showed a absolutely different pattern and was over 100 
times higher expressed than Sox2 and Oct-4; cMyc also maintained consistently 
up-regulated levels at passage 7. Differences of the Sox2, Oct-4 and c-Myc among 
passages were statistically significant (p<0.05). Moreover, mRNA expression level of 
Sox2 (Fig 4D) and Oct-4 (Fig 4E) showed significant upregulation in PDLCs with 
rhBMP4 treatment at passage 7(*p<0.05). Albeit the mRNA expression level of 
c-Myc showed no significant difference compared with the control group (p>0.05, 
Fig 4F), implying the similar expression pattern and potential cooperative interaction 
between Sox2 and Oct-4. We further investigated whether the basal endogenous 
BMP-4 level had any impact on the expression of Sox2, Oct-4 and cMyc in PDLCs. It 
was found that the basal endogenous BMP-4 mRNA level was relatively low in 
PDLCs and no significant alternations were found in the mRNA expression of BMP-4 
from passage 1 to 7 (p>0.05, Fig 4G), indicating there was no direct correlation 
between endogenous BMP-4 level and the expression of Sox2, Oct-4 and c-Myc in 
PDLCs. 
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Discussion 
Extended in vitro culture in the current methodology is known to cause morphologic 
alternations, loss expression of pluripotent markers and widespread senescence [17, 
18]. The PDLCs used in this study showed significant cell senescence and 
morphological changes at late passages in the normal cell growth media. It is known 
that loss of regeneration capacity of MSCs can be rejuvenated by altered extracellular 
microenvironment [18] and microenvironment produces systemic factors to modulate 
molecular pathways which control the regenerative properties and support tissue 
regeneration [8, 17]. Since Oct4, Sox2 and c-Myc cooperatively maintain or induce 
the regulatory network responsible for self-renewal and pluripotency, it has been 
assumed that these genes have important and conserved functions in stem cells. 
However, the specific functions of these markers in various cells remain poorly 
defined. Sox2 belongs to the SRY-related HMG box transcription factor family and 
plays essential role in regulation of pluripotency of ESCs during early embryonic 
development [21,22]. Oct-4 is an essential regulator of pluripotency in ESCs and 
iPSCs [23]. Oct-4 and Sox2 levels in human ESCs are characteristic of the 
undifferentiated state, loss expression results in differentiation and progressive loss of 
pluripotency [11,24]. Sox2 and Oct-4, master transcription factors for maintenance of 
the undifferentiated state and self-renewal capability, can interact cooperatively to 
activate the expression of pluripotency factors like c-Myc, FGF4, Nanog and 
determine cell fate [21, 25]. V-myc myelocytomatosis viral oncogene homolog 
(c-Myc), a frequent contributory oncogene in tumors, can mediate reprogramming 
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through altering telomere of a developmentally restricted cell [26].  
 
Sox2, Oct-4 and c-Myc are transcriptional factors described as a nuclear protein. 
Although the molecular basis of these transcriptional factors to control cell fate is not 
clear, yet it has been demonstrated that nuclear import is a requirement for their 
function [4, 6]. In these cases, when cytoplasmic location is detected, the nuclear 
envelope may be disassembled, allowing protein exchange between nucleus and 
cytoplasmic compartments. Although the functional relevance of maintaining Sox2, 
Oct-4 and c-Myc in the nucleus is not known, the activity of Sox2, Oct-4 and c-Myc 
in PDLCs are associated with the multilineage differentiation potential and may be 
controlled by nucleus-cytoplasmic shuttling [28].  
 
Adding growth factors to culture solution and improving the culture condition is a 
simple and effective way of delivering the growth factor signals to cells. As known 
from in vivo studies, Bone morphogenetic factors (BMPs), members of TGF-β 
superfamily have a notable value in development and differentiation [16]. BMPs, 
presented in a wide variety of stem cell niches to maintain cell functions, can replace 
Klf4 to initiate reprogramming and boost the efficiency of Oct-4/Sox2 complex and 
single-factor Oct-4 mediated reprogramming of mouse embryonic fibroblasts [29].  
 
BMP-4 is reported to maintain cell proliferation and pluripotent state through Smad, 
PI3K/Akt, and Wnt1/beta-catenin in mouse ESCs [32]. Interestingly, the microarray 
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profiles of Oct-4 knockdown and BMP-4 treated H1 cells were compared. There are 
1,395 Oct-4 responsive genes and 1,466 BMP-4 responsive genes identified, which 
showed significant overlap [33]. Moreover, it is reported that mouse skin 
keratinocytes treated with BMP-4 can be reprogrammed to more developmentally 
potent stage, and re-differentiate into neuronal lineage cells through upregulating 
Oct-4, Sox-2, Nanog, Utf1 and Rex-1[34]. Stromal fibroblasts from head/neck cancer 
tissues produce growth factors, including BMP-4, which affects the functional 
properties and remains undifferentiated stage of keratinocytes with in vitro culture, 
including promotion of epithelial-mesenchymal transition (EMT)-like alterations. 
Oct-4 is reported to centralized on nucleus of human tongue OSCC cell line Tca8113 
after induced by BMP-4, with upregulation of ABCG2, hTERT, CD44 and Bmi-1[35]. 
This is consistent with our result that Sox2, Oct-4 and c-Myc maintained nucleus 
location and relatively high mRNA expression even at late passages in PDLCs with 
rhBMP4 induction, revealing BMP-4 may provide a suitable microenvironment to 
maintain cells in an undifferentiated stage. This suggests the effects seen with BMP-4 
treatment may be due to transcriptional regulation through Sox2, Oct-4 and 
c-Myc-signaling pathway. Moreover, the present study revealed that BMP-4 
promoted cell growth, proliferation, arrested PDLC in S and G2/M phase of cell cycle 
and enhancing PI value. The present study indicates that although BMP-4 alone may 
not be sufficient to lead to direct reprogramming[4, 7], it may play an essential role in 
modification of microenvironment and culture system which maintain cell growth and 
the expression of multipotency markers. Therefore, BMP-4 may be an effective way 
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to optimize the culture environment and improve stem cell properties of PDLCs 
during long-term culture. 
 
In summary, this study revealed BMP-4 contributes to promote cell growth, 
proliferation through cell cycle modulation, and maintains the expression of 
reprogramming markers even at late passages. This is of great importance since it 
suggested that microenvironment can manipulate key molecular pathways controlling 
stemness of PDLCs. However, future studies are required to investigate the molecular 
mechanisms of BMP4 in maintaining the pluripotency with long term in vitro culture. 
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Table 1. Primer sequences used in quantitative real-time PCR 
Gene Primers 
Sox2 
 
Oct-4 
 
c-Myc 
 
BMP-4 
 
18s 
 
Forward: 5’-CAC TGF CCC TCT CAC ACA TG-3’ 
Reverse : 5’-CCC ATT TCC CTC GTT TTT CTT-3’ 
Forward: 5’-GCT CGA GAA GGA TGT GGT C-3’ 
Reverse : 5’-ATC CTC TCG TTG TGC ATA GTC G-3’ 
Forward: 5’-CGT CTC CAC ACA TCA GCA CAA-3’ 
Reverse : 5’-TCT TGG CAG CAG GAT AGT CCT T-3’ 
Forward: 5’-TAGCAAGAGTGCCGTCATTCC-3’ 
Reverse : 5’-GCGCTCAGGATACTCAAGACC-3’ 
Forward: 5’-TCG GAA CTG AGG CCA TGA TTA AG-3’ 
Reverse : 5’-TCT TCG AAC CTC CGA CTT TCG-3’ 
 
 
 
Table 1. Primer sequences used in quantitative real-time PCR 
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Table 2. The cell cycle of PDLCs from passage 1 to 8 without/with rhBMP4 induction 
(mean±SD%, n=3) 
Passage G0/G1 G2/M S PI=(S+G2/M)% 
Passage 1 control 82.9±1.1* 7.55±0.3 9.6±1.2 17.1 
Passage 1 BMP-4 76.6±1.7 10.1±1.1* 13.4±0.7* 23.4* 
Passage 2 control 86.1±2.0* 6±0.7 7.93±1.3 13.9 
Passage 2 BMP-4 78.8±0.9 9.83±1.2* 11.4±1.1* 21.2* 
Passage 3 control 89±1.3* 4.81±0.6 6.15±0.8 11 
Passage 3 BMP-4 79.9±3.0 5.87±0.8 14.3±0.3* 20.1* 
Passage 4 control 90±2.7* 4±0.2 6.04±0.2 10 
Passage 4 BMP-4 84.3±1.9 4.64±0.4 11.1±1.2* 15.7* 
Passage 5 control 88.2±2.7* 4.33±1.0 7.49±1.3 11.8 
Passage 5 BMP-4 83.9±1.2 4.32±1.1 11.8±0.9* 16.1* 
Passage 6 control 89.4±2.3* 4.48±0.3 6.13±0.7 10.6 
Passage 6 BMP-4 80.6±1.6 6.1±0.7* 13.3±1.7* 19.4* 
Passage 7 control 85.6±2.8* 4.5±0.6 9.89±0.3 14.4 
Passage 7 BMP-4 72.1±2.3 4.88±0.1 23±1.8** 27.9** 
Passage 8 control 88±2.0* 3.06±0.2 8.9±1.1 12 
Passage 8 BMP-4 75.2±2.7 2.66±0.8 22.2±0.3** 24.8** 
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Table 2. The cell cycle of PDLCs from passage 1 to 8 without/with rhBMP4 
induction 
An sinificant increase in the percentage of PDLCs in S phase (passage 1 to 8, *P < 
0.05, ** P < 0.001) and G2/M (passage 1, 2 and 6, *P < 0.05) with a corresponding 
decline in G0/G1 phase (passage 1 to 8, *P < 0.05) was presented. 
 
Figure 1. Morphological characteristics of PDLCs at various passages 
PDLCs at passage 1 showed a fibroblast-like morphology and single monolayer 
growing pattern, well-spread attaching to the flask(A,×100). PDLCs displayed 
enlarged cell size, spindle shape, increased nuclear/cytoplasm ratio and cell secrection 
at passage 3, 5 and 7(B-D,×100). After treated with rhBMP4, PDLCs displayed 
smaller cell size, decreased nuclear/cytoplasm ratio and cell secrection(E,×100). 
PDLCs from passage 7 were strongly positive for SA-β-gal activity, which stained 
an intense blue color (I,×100), PDLCs from passage 5 (H,×100) showed blue 
staining but not as intense as the cells from passage 7. However, PDLCs from passage 
1 (F,×100), passage 3 (G,×100) and rhBMP4 treated group (passage 7, J,×100) did 
not show any obvious blue staining. 
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Figure 2. Cell growth, proliferation and cell cycle of PDLCs at various passages 
The cell number of PDLCs with rhBMP4 treatment was significantly upregulated at 
various passage compared with the control groups (I, *p<0.05). Treatment with 
rhBMP significantly stimulated the cell proliferation of PDLCs at passage 5 and 7 (J, 
*p<0.05), albeit no significant difference at passage 1 and 3 (J, p>0.05).  
The cell cycle of PDLCs from passage 1 to 8 was determined by FACS (A-H). 
Whereas only the data of PDLCs from passage 1(A), 3(B), 5(C), 7 (D) in control 
group and passage 1(E), 3(F), 5(G), 7 (H) in rhBMP4 induction group was presented. 
The percentage of PI=(S+G2/M)% in rhBMP4 treated PDLCs from passage 1 to 8 
were significantly higher than the control group (K, *P < 0.05, ** P < 0.001).  
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Figure 3. Immunofluorescent staining of Sox2, Oct-4 and c-Myc in PDLCs at 
various passages 
Tense staining of Sox2 (A-E), Oct-4 (F-J) and c-Myc (K-O) was detected in the 
nucleus of PDLCs at passage 1(A, F, K,×400) and 3(B, G, L,×400). Sox2, Oct-4 
and c-Myc lost their nucleus location, yet still showed cytoplasm staining in PDLCs at 
passage 5(C, H, M, ×400) and 7(D, I, N,×400). However, after treated with 
rhBMP4, Sox2 (E,×400), Oct-4 (J,×400) and c-Myc (O,×400) maintained nucleus 
location in PDLCs even at passage 7. 
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Figure 4. Nucleus expression ratio and mRNA expression of Sox2, Oct-4, c-Myc 
and BMP-4 in PDLCs at various passages 
The nucleus expression ratio of Sox2 (A), Oct-4 (B) and c-Myc (C) displayed no 
significant difference between passage 1 and 3(p>0.05), albeit significantly decreased 
at passage 5 and 7(*p<0.05). The mRNA expression of Sox2 (D) and Oct-4 (E) 
significantly increased and peaked at passage 3, then decreased significantly 
afterwards (p<0.05). Whereas mRNA expression of c-Myc maintained consistently 
upregulation until passage 7 (F, p<0.05). No significant alternations were found in the 
mRNA expression of BMP-4 from passage 1 to 7 (p>0.05, G). 
 
After treated with rhBMP4, nucleus expression ratio of Sox2(A), Oct-4 (B) and 
c-Myc (C) displayed significant upregulation at passage 5 and 7 compared with the 
untreated groups (*p<0.05), although cells from passage 1 and 3 showed no 
significant difference (p>0.05). The mRNA expression level of Sox2 (D) and Oct-4 
(E) displayed significantly increased (*p<0.05) at passage 7 compared with the 
untreated groups, albeit c-Myc showed no significant difference at all passages 
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compared with the control groups (F, p>0.05). 
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Morphological characteristics of PDLCs at various passages 
PDLCs at passage 1 showed a fibroblast-like morphology and single monolayer growing pattern, 
well-spread attaching to the flask(A,×100). PDLCs displayed enlarged cell size, spindle shape, 
increased nuclear/cytoplasm ratio and cell secrection at passage 3, 5 and 7(B-D,×100). After 
treated with rhBMP4, PDLCs displayed smaller cell size, decreased nuclear/cytoplasm ratio and 
cell secrection(E,×100). PDLCs from passage 7 were strongly positive for SA-β-gal activity, 
which stained an intense blue color (I,×100), PDLCs from passage 5 (H,×100) showed blue 
staining but not as intense as the cells from passage 7. However, PDLCs from passage 1 (F,×100), 
passage 3 (G,×100) and rhBMP4 treated group (passage 7, J,×100) did not show any obvious blue 
staining. 
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Immunofluorescent staining of Sox2, Oct-4 and c-Myc in PDLCs at various passages 
Tense staining of Sox2 (A-E), Oct-4 (F-J) and c-Myc (K-O) was detected in the nucleus of PDLCs 
at passage 1(A, F, K,×400) and 3(B, G, L,×400). Sox2, Oct-4 and c-Myc lost their nucleus 
location, yet still showed cytoplasm staining in PDLCs at passage 5(C, H, M, ×400) and 7(D, I, 
N,×400). However, after treated with rhBMP4, Sox2 (E,×400), Oct-4 (J,×400) and c-Myc (O,×400) 
maintained nucleus location in PDLCs even at passage 7. 
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